Study Summary
This trial is testing whether adding albumin to diuretics helps people with cirrhosis and fluid retention.
- Liver Cirrhosis
- Fluid Overload
- Volume Overload
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
2 Primary · 4 Secondary · Reporting Duration: 1 year
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Combination of furosemide (Lasix) and albumin
1 of 2
Furosemide (Lasix) alone
1 of 2
Active Control
150 Total Participants · 2 Treatment Groups
Primary Treatment: Combination of furosemide (Lasix) and albumin · No Placebo Group · Phase 4
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What therapeutic purpose does the amalgamation of furosemide (Lasix) and albumin serve?
"For the treatment of mediastinitis, furosemide (Lasix) and albumin are administered in tandem. It has further application for alleviating liver failure, acute edema, as well as preventing hypovolemia." - Anonymous Online Contributor
What is the anticipated outcome of this clinical investigation?
"Over a time frame of 2-7 days, this trial will be assessing changes in weight while secondary outcomes include patient survival rate, alteration in renal function as measured by serum creatinine levels, and the number of readmissions within 30 days post-discharge." - Anonymous Online Contributor
How many individuals are enrolled in this trial at present?
"Affirmative, the information on clinicaltrials.gov illustrates that this medicinal trial is currently enrolling participants. This endeavor was first announced on December 19th 2019 and most recently edited January 8th 2020. 150 people are needed to join from one single medical centre." - Anonymous Online Contributor
Has the utilization of furosemide (Lasix) in tandem with albumin been ratified by the FDA?
"Due to the fact that this is a Phase 4 trial, implying that the combination of furosemide (Lasix) and albumin has already been approved, we rated its safety as 3." - Anonymous Online Contributor
Are there still opportunities for individuals to participate in this experiment?
"As shown on clinicaltrials.gov, this medical trial is actively seeking participants; the initial post date was December 19th 2019 and edits were made as recent as January 8th 2020." - Anonymous Online Contributor
Is this medical experiment the inaugural undertaking of its type?
"Since the 2007 pilot study sponsored by Celgene Corporation, which saw 47 participants trialling Combination of furosemide (Lasix) and albumin, this medication has been approved for Phase 1 & 2 drug trials. Currently, there are 147 active studies in 922 cities across 35 nations." - Anonymous Online Contributor